[1] Kiviharju TM, Lecane PS, Sellers RG, et al. Antiproliferative and proapoptotic activities of triptolide(PG490), a natural product entering clinical trials,on primary cultures of human prostatic epithelial cells[J]. Clin Cancer Res, 2002, 8(8):2666-2674. [2] Caspi O, Polak A. Traditional immunosuppression-Lei Gong Teng in modern medicine[J]. Harefuah, 2013,152(7):404-409,433. [3] Meng C, Zhu H, Song H, et al. Targets and molecular mechanisms of triptolide in cancer therapy[J]. Chin J Cancer Res, 2014, 26(5):622-626. [4] Zeng R, Zeng L, Chen Y, et al. Triptolide-induced apoptosis by inactivating nuclear factor-kappa B apoptotic pathway in multiple myeloma in vitro[J]. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(4):446-451. [5] Agarwal P, Alzrigat M, Párraga AA, et al. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target[J]. Oncotarget, 2016, 7(6):6809-6823. [6] 傅海英, 沈建箴. 雷公藤内酯醇对急性淋巴细胞白血病Molt4细胞系p15基因表达的影响[J]. 中华内科杂志, 2005, 44(4):301-302. [7] 吴雪梅, 沈建箴, 喻爱芳, 等. 雷公藤内酯醇逆转人恶性淋巴瘤细胞株CA46细胞P16基因甲基化的实验研究[J]. 中国医药导刊, 2008, 10(8):1211-1212. [8] 吴雪梅, 沈建箴, 沈松菲, 等. 雷公藤内酯醇逆转Jurkat细胞APC基因甲基化及其机制的初步研究[J]. 中国实验血液学杂志, 2010, 18(4):866-872. [9] Zhang C, Cui GH, Liu F, et al. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro[J]. Acta pharmacol Sin, 2006, 27(11):1438-1446. [10] Meng HT, Zhu L, Ni WM, et al. Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1[J]. Acta Pharmacol Sin, 2011, 32(4):503-511. [11] Catasus L, Gallardo A, Cuatrecasas M, et al. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis[J]. Mod Pathol, 2009, 22(4):522-529. [12] 梅怡, 史永照, 冯雯, 等. 雷公藤甲素对乳腺癌细胞P53、P73基因甲基化的影响以及对细胞增殖的抑制作用[J]. 第二军医大学学报, 2012, 33(4):380-384. [13] 杨洋, 董红娟, 高广勋, 等. 雷公藤内酯醇对硼替佐米诱导多发性骨髓瘤细胞凋亡的影响[J]. 中国实验血液学杂志, 2012, 20(2):335-338. [14] 武磊, 刘晓华, 王天辉, 等. 组蛋白去乙酰化酶抑制剂对大鼠应激性心肌损伤的保护作用[J]. 中国应用生理学杂志, 2015, 31(3):193-196. [15] 吉海龙, 史鹏飞, 周洁, 等. 脾源性酪氨酸激酶基因启动子甲基化与髓母细胞瘤细胞侵袭转移的关系[J]. 中国应用生理学杂志, 2016, 32(2):132-136. [16] Martinez-Garcia E, Popovic R, Min DJ, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells[J]. Blood, 2011, 117(1):211-220. [17] Zhao F, Chen Y, Li R, et al. Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro[J]. Toxicology, 2010, 267(1-3):70-79. [18] Hamamoto R, Furukawa Y, Morita M, et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells[J]. Nat Cell Biol, 2004, 6(8):731-740. [19] Kim H, Heo K, Kim JH, et al. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription[J]. J Biol Chem, 2009, 284(30):19867-19877. [20] Hervouet E, Cartron PF, Jouvenot M, et al. Epigenetic regulation of estrogen signaling in breast cancer[J]. Epigenetics, 2013, 8(3):237-245. [21] Scoumanne A, Chen X. Protein methylation:a new mechanism of p53 tumor suppressor regulation[J]. Histol Histopathol, 2008, 23(9):1143-1149. [22] Kontaki H,Talianidis I.Lysine methylation regulates E2F1-induced cell death[J]. Mol cell, 2010, 39(1):152-160. |